Elemental calcium intake associated with calcium acetate/calcium carbonate in the treatment of hyperphosphatemia

le Wilson, Rosamund J, Copley, J Brian
Foilsithe in Drugs Context (2017)

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of d...

le Hutchison Alastair J, Gill Maggie, Copley J Brian, Poole Lynne, Wilson Rosamund J
Foilsithe 2013-02-01

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of d...

le Hutchison, Alastair J, Gill, Maggie, Copley, J Brian, Poole, Lynne, Wilson, Rosamund J
Foilsithe 2013

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients

le Farrand, Kimberly F, Copley, J Brian, Heise, Jamie, Fridman, Moshe, Keith, Michael S, Poole, Lynne
Foilsithe 2014

Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a ph...

le Ureña-Torres, Pablo, Prié, Dominique, Keddad, Karim, Preston, Peter, Wilde, Paul, Wan, Hong, Copley, J Brian
Foilsithe 2014

PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis

le Beck, Laurence H., Berasi, Stephen P., Copley, J. Brian, Gorman, Donal, Levy, Daniel I., Lim, Chay Ngee, Henderson, Joel M., Salant, David J., Lu, Weining
Foilsithe in Kidney Int Rep (2021)